Oncology and Hematology
Episodes 177-192 of 304
- Project Oncology®
Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
Vivek Subbiah, MD
- Project Oncology®
Impact of Infertility & Elective Fertility Among Female Oncologists
Emily MacDuffie, MD
- Project Oncology®
Combating the Complexities of Cancer Care During Pregnancy
Alison Wakoff Loren, MD, MSCE
Jacob Sands, MD
Joseph O. Jacobson, MD
- Project Oncology®
Managing Immunotherapy Toxicities in Lung Cancer Patients
Jacob Sands, MD
Aliyah Pabani, MD
Charles Turck, PharmD, BCPS, BCCCP
Megan Kruse, MD
- Project Oncology®
A Review of the Multiple Myeloma Treatment Journey
Charles Turck, PharmD, BCPS, BCCCP
Morie Gertz, MD, MACP
Aaron Rosenberg, MD, MS
- Project Oncology®
Exploring the Role of Biomarkers in Lung Cancer Treatment
Jacob Sands, MD
Biagio Ricciuti, MD
- Project Oncology®
Recognizing the Role of Capmatinib for METex14 in NSCLC
Jacob Sands, MD
Edward B. Garon, MD, MS
- Project Oncology®
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Pavani Chalasani, MD, MPH
Erika Hamilton, MD
- Project Oncology®
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
Pavani Chalasani, MD, MPH
Nan Chen, MD
- Project Oncology®
Treating Metastatic Breast Cancer: Where Are We Now?
Pavani Chalasani, MD, MPH
Seema A. Khan, MD
- Project Oncology®
Exploring Drug Shortages in the U.S.: What Do We Need to Know?
Jacob Sands, MD
Maya Leiva, PharmD, BCOP
- Project Oncology®
Bridging the Gaps in Care: How to Improve Care for LGBTQ+ Patients
Jacob Sands, MD
Maya Leiva, PharmD, BCOP
- Project Oncology®
Conversations Around Chemotherapy: Do All of Your Patients Need It?
Pavani Chalasani, MD, MPH
Kevin Kalinsky MD, MS
- Project Oncology®
A Look at the Therapeutic Landscape for Metastatic Breast Cancer
Pavani Chalasani, MD, MPH
Aditya Bardia, MD, MPH